Weissach Capital is a globally oriented healthcare and pharmaceutical solutions company, with 30 years of experience in the licensing, distribution, and commercialization of high-quality medical products across international markets. We serve as a strategic partner to pharmaceutical manufacturers, wholesalers, hospitals, health ministries
Weissach Capital is a globally oriented healthcare and pharmaceutical solutions company, with 30 years of experience in the licensing, distribution, and commercialization of high-quality medical products across international markets. We serve as a strategic partner to pharmaceutical manufacturers, wholesalers, hospitals, health ministries, and NGOs—providing end-to-end solutions in human and animal health, medical devices, and diagnostics.
Weissach Capital bridges innovation and access in healthcare.
We license, register, import, and distribute a diverse portfolio of pharmaceutical and healthcare products—supporting manufacturers and institutions in delivering life-saving solutions to the people who need them most. From dossier ownership and regulatory services to global tr
Weissach Capital bridges innovation and access in healthcare.
We license, register, import, and distribute a diverse portfolio of pharmaceutical and healthcare products—supporting manufacturers and institutions in delivering life-saving solutions to the people who need them most. From dossier ownership and regulatory services to global trade and logistics, we are involved at every step of the value chain.
Agile. Transparent. Globally compliant.
Our model is built on trust, speed, and regulatory excellence. We operate as your long-term partner—navigating complex markets with clarity, managing multi-country registrations, handling cold-chain logistics, and ensuring that every shipment meets the highest global standards.
Transforming global healthcare through intelligent partnerships.
We aspire to redefine how healthcare is accessed and delivered by being the most dependable and forward-thinking capital partner for pharmaceutical and medical innovation—across emerging and developed markets alike.